Sinobioway Group
Beijing Sinobioway Group Co., Ltd. (Sinobioway), one of the three main corporations affiliated to Peking University, focuses on bio-industry development and bioeconomy system establishment. Sinobioway has invested in six business areas: bio-medicine, bio-agriculture, bio-energy, bio-environment, bio-service and bio-manufacturing .With Such achievements, Sinobioway has become a flagship of bio-industry in China and will become one of the most potential competitors in the world.
Over the 20 years development, Sinobioway has made significant contributions to the growth of bio-industries in China by its pioneering work and breakthroughs in this field, and it has accomplished remarkable achievements and got three major competitive advantages “solid industry foundation, innovative economic model and unique development philosophy”. These extraordinary achievements include:
- successfully marketing the first gene engineering drug “human recombinant interferon a1b (SINOGEN)” with independent intellectual property rights in China, which was the top brand in Chinese interferon market;
- successfully managing the first modern Chinese bio-pharmaceutical company, Shenzhen Kexing Biotech Co., Ltd., creating a miracle in the history of Chinese bio-industry;
- Successfully manufacturing the first “Inactivated SARS Vaccine”, the first influzenza A (H1N1) vaccine (Panlive 1®) in the world and the first bird flu vaccine for human in China, as well as the first hand-foot-mouth disease vaccine (currently in phase III clinical trial) in the world by Beijing Sinovac Biotech Co., Ltd.;
- Successfully developing and manufacturing the first therapeutic drug for neural injury in the world “Nerve Growth Factor” by Xiamen Bioway Biotech Co. Ltd., which is the first Medical or Physiological Nobel prize awarded findings marketed by Chinese;
- Successfully developing the third generation of hybrid-breeding technology by Beijing Kaituo Agriculture Biotech Co., Ltd., which will lead to the third agricultural revolution;
- leading the development of the new generation of information technology in the world with the bio-intelligence technology (the core technology of the fifth generation of computer) of Beijing Bosi Bio-intelligence Technology Co., Ltd. In particular, Sinobioway has established the first “bioeconomy incubator” in the world, created bioeconomy theory, constructed bioeconomy system and bio-recombination model. Sinobioway is the origin of the world bio-economy.
Sinobioway is marking great effort to achieve the goal of creating a leading enterprise, nurturing an excellent team and triggering an industrial revolution by constructing the first bio-economic system (including industry system, research system, and finance system) in the world, to become the flagship in the bioeconomy era, and eventually to contribute to the peaceful rising and sustainable development of China.
